BMN 111
111-302
Phase 3 small_molecule active
Quick answer
BMN 111 for Achondroplasia is a Phase 3 program (small_molecule) at BioMarin International Limited with 6 ClinicalTrials.gov record(s).
Program details
- Company
- BioMarin International Limited
- Indication
- Achondroplasia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active